World Kidney Day Red Carpet Event
Kidney Cancer Canada is proud to present THE ROBOT movie premiere on March 11, World Kidney Cancer Day at 7 pm EST. THE ROBOT starring Dr. Stephen Pautler who demystifies robotic assisted surgery and answers frequently asked questions. This movie feature will be edited and added...
Patient & Caregiver Coffee-Chat | March
March is National Kidney Month LINKS TO PATIENT & CAREGIVER COFFEE-CHATS ENGLISH Coffee-Chat | March 2, 3 pm EST FRENCH Coffee-Chat | March 8, 7 pm EST March is National Kidney Month and what better way to start celebrating this special month than with our Patient & Caregiver Online...
ASCO GU 2021
Webinar hosted by the Kidney Cancer Coalition: What's New in Kidney Cancer Research? The Kidney Cancer Coaltion held a webinar on the latest research in kidney cancer from ASCO-GU. Four leading experts shared the research in patient-friendly language and answered questions. Learn what they heard and...
New patient resource
We have a great new resource for patients starting or undergoing immuno-oncology therapy. Developed by Bristol Myers Squibb, Your introduction to immuno-oncology therapy has information about cancer immunotherapy, your healthcare team, and other resources that can help you. You will also find a 6-month calendar that can...
New Normal, Same Cancer
Canadian Oncology Community Unites For World Cancer Day: Shedding Light on the Impact of Covid-19 on Cancer Care Oncologists estimate cancer diagnoses down 25 per cent in some areas as a result of COVID-19 Some oncologists are also reporting an increase in later stage...
Patient & Caregiver Coffee-Chat
Join us at our first coffee-chat of the new year. LINKS TO PATIENT & CAREGIVER COFFEE-CHATS ENGLISH Coffee-Chat | January 26, 7 pm EST FRENCH Coffee-Chat | January 27, 7 pm EST Since the beginning of the pandemic, we changed our in-person coffee-chats to virtual coffee-chats. The participation has...
Dr. Michael A. S. Jewett appointed to the Order of Canada
Dr. Michael A. S. Jewett appointed to the Order of Canada for his life-saving innovations in surgical oncology and for his advocacy of patient-centred clinical care. The Order of Canada is one of our country’s highest civilian honours. Its Companions, Officers and Members take to heart...
How does the International Kidney Cancer Coalition (IKCC) survey help kidney cancer patients in Canada?
The survey is designed to ask patients across 30 countries the same questions about their experiences with kidney cancer allowing for the identification of best practices and unmet needs related to patient access to care, quality of life and involvement in clinical trials. Although the data...
Annual Fundraising Campaign
Please help us to continue to support kidney cancer patients, their caregivers and families. Your donations provide support, education, and advocacy for our kidney cancer community. Better treatments, better diagnosis and support for many challenges as they manage their disease. We appreciate these are difficult times for everyone,...
National Patient and Caregiver Annual Forum 2020 now online
[mkd_button size="" type="" text="FORUM PROGRAM HERE" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://online.fliphtml5.com/fexz/ldbq/" target="_blank" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] [mkd_button size="" type="" text="WATCH FORUM MEETING HERE" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://www.kidneycancercanada.ca/news-events/watch-past-meetings/2020-national-patient-caregiver-annual-forum/" target="_self" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] The National...
Patient & Caregiver Coffee-Chats
Let’s connect before the Holiday Season! LINKS TO ENGLISH COFFEE-CHATS PATIENT Coffee-Chat | December 15, 2 pm EST CAREGIVER Coffee-Chat | December 16, 2 pm EST LINK TO FRENCH COFFEE-CHATS This Holiday Season is not our “normal. News about vaccines is encouraging but anxiety levels are running high with COVID-19...
Mindfulness & Mental Health Webinar Now Online
[mkd_button size="" type="" text="watch webinar here" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://www.kidneycancercanada.ca/news-events/watch-past-meetings/mindfulness-and-mental-health/" target="_self" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] The COVID-19 pandemic has added another level of stress and anxiety for patients living with cancer due to things like delayed scans, telephone instead of in-clinic doctors...
International Kidney Cancer Coalition Global Patient Survey
The International Kidney Cancer Coalition's (IKCC) Global Patient Survey is a survey, conducted every two years, designed to identify geographic variations in patient experience to highlight best practices and unmet needs related to patient access to care, quality of life and involvement in clinical trials. The...
Research Study Recruitment Request – Urological Cancer Patient’s Perceptions on Cannabis
Are you currently using cannabis? A research study being done through the Urological Cancer Centre for Research and Innovation in Hamilton, Ontario, is looking at Canadian urological patient perceptions surrounding the use of cannabis for cancer. They are looking for patients who are currently using cannabis to...
New resources for patients and caregivers
The Ottawa Hospital Uro-Oncology Research Group is proud to have designed and developed multiple patient decision aids. Urologist, Dr. Luke Lavallée, created the decision aids for kidney cancer patients. The objective is to help patients discuss treatment options with their doctor. This decision aid was created...
Highlights from the ESMO Virtual Congress 2020
Source: International Kidney Cancer Coalition (IKCC) As a result of the COVID-19 pandemic, this year’s European Society of Medical Oncology (ESMO) congress was held virtually from 19-21 September 2020. The virtual presentations are available to view on the ESMO website if you have previously logged in to the site. The...
Coffee-Chat for Caregivers only! September 25
This month, our coffee-chat will be for caregivers only. We know how a cancer diagnosis strongly affects the whole family and the caregivers are at the centre of it all. They are the pillars of strength in the care pathway, the ones that ask the...
Clinical trial – Many Centres now recruiting
A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients with Advanced Kidney Cancer Trial ID: NCT04088500 A clinical trial that all metastatic kidney cancer patients should know about if they have previously taken the combination of nivolumab and ipilimumab. The study will investigate whether the combination can be...
A month of September dedicated to Heroes for the Lowe’s Canada network
Throughout the month of September, RONA, in Elmsdale, Nova Scotia will raise funds to support Kidney Cancer Canada as part of the Lowe’s Canada Heroes campaign. If you are in the Elmsdale, NS area and need items for your home improvement projects shop at the RONA...
Move to Beat Cancer – Save the date!
SEPTEMBER 18-20, 2020 The MOVE TO BEAT CANCER is a project that brings people and their communities together virtually in a dynamic, social and festive way to create awareness about cancer prevention and to raise money for patient programs and research. "We are very excited with this...
Dave Trbizan Legacy Campaign
[mkd_button size="" type="" text="KIDNEYCANCERCANADA.CA/DAVETRBIZANLEGACY" custom_class="" icon_pack="font_awesome" fa_icon="" link="www.kidneycancercanada.ca/davetrbizanlegacy" target="_blank" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] Many of you have followed and donated to the Dave Trbizan fundraising campaign that he started over 3 years ago and managed to raise more than $100,000 for...
Shared Decision Making for Kidney Cancer Patients – Perspectives from an Oncologist and a Patient
Join Dr. Naomi Haas and Deb Maskens online September 2nd at 1:30 pm EDT when experts discuss the various decision points along the treatment path. Learn about seeking second opinions, clinical trials, determining what is right for you, practical tips about being an active partner in...
Cancer survivors needed for an online survey
The Exercise Oncology Lab (Principal Investigator: Linda Trinh, PhD) at the University of Toronto is interested in understanding the unique experiences of cancer survivors during the COVID-19 pandemic and how it has impacted the physical activity behaviors and mental health of cancer survivors. The Exercise Oncology...
Online Coffee Chat – August 21
Coffee anyone? Join us for our online coffee-chat, Friday August 21 at 2 pm EDT. Our online coffee-chats are a great way to stay connected and receive support from kidney cancer patients and caregivers within our community. Not everyone is comfortable with this format but we...
Highlights from the ASCO 2020 Virtual Scientific Programme
Source: International Kidney Cancer Coalition (IKCC) As a result of the COVID-19 pandemic, this year’s American Society of Clinical Oncology (ASCO) Annual Meeting was held virtually from 29-31 May 2020. The virtual presentations are available to view on the ASCO website. The International Kidney Cancer Coalition...
Management of Kidney Cancer during COVID-19 Webinar
In this webinar on Kidney Cancer, How I Treat COVID-19 Webinar initiative, hosts an expert in the field and a patient/survivor. Discussion topics include the treatment of kidney cancer before and during the pandemic by Dr. Anil Kapoor, Uro-Oncologist, a statement from kidney cancer survivors Nancy...
World Kidney Cancer Day promotes physical activity for both the prevention and treatment of kidney cancer
Ten years ago, if you were diagnosed with any cancer, you’d probably be told to rest and do as little physical activity as possible. Today, you’re more likely to be told the opposite. Studies now confirm the beneficial role that regular physical activity plays in...
Webinar May 27: Optimal Management of Urologic Oncology during COVID-19
[mkd_button size="" type="" text="Register" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://zoom.us/webinar/register/WN_G--fhtVsS5WmgIVk9SEKGg" target="_blank" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] The Urologic Cancer Centre for Research & Innovation (UCCRI) hosts a virtual event to discuss the optimal management of urologic oncology during the COVID-19 pandemic. This meeting will focus...
Giving Tuesday Coffee-Chat – May 5
On Giving Tuesday we will host two online Coffee-Chats; an opportunity to share how you are and how you are coping. Are you worried about your treatment or changes in your treatment schedule Questions? Concerns? Let’s talk over a hot cup of coffee and share...
Giving Tuesday – A message of hope and unity
[mkd_button size="" type="" text="Donate online" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://interland3.donorperfect.net/weblink/WebLink.aspx?name=E344126QE&id=39" target="_self" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] Kidney Cancer Canada is your front-line support service for kidney cancer Patients and caregivers are being asked to be at their strongest in this time of uncertainty. So...
Will COVID-19 affect my treatment plan?
The Canadian Urological Association published a guidance document with the participation of eighteen academic genitourinary (GU) medical oncologists from 11 cancer centres across Canada to provide recommendations for managing patients during the COVID-19 pandemic. [mkd_button size="" type="" text="See recommendations outlined for kidney cancer treatment" custom_class="" icon_pack="font_awesome"...
Save the dates – Upcoming Online Coffee-Chats
It was truly remarkable to connect with our community through our online coffee-chat. The support, easy conversation and the feeling of safety within this new format of communication was appreciated and commended by all participants. In these times of social distancing, we feel the need to...
Free online exercise classes
Instructor Sarah Weller, Clinical Exercise Physiologist holds online exercise classes for cancer patients three times a week live on Instagram. The classes are held from 11 am to 12 pm EDT to help you get active, build strength, improve fitness and increase flexibility: [mkd_icon icon_pack="font_awesome" fa_icon="circle" size=""...
National Caregiver Day
Recognizing caring Canadians From 5 minutes to an hour or even days, no amount is too small to show you care 8 million Canadians provide unpaid care to support someone with a long-term health condition, a physical or mental disability or problems related to aging. While caring...
Cancer care in Canada during the COVID-19 emergency
[mkd_button size="" type="" text="Take the 5-question survey" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://www.surveymonkey.com/r/NB6ZQRD?fbclid=IwAR0gdvW0EktLfepdnQg142XvbbpJUIYWtOctKJP3nJ-LKVsHM9sV0gCOw_8" target="_blank" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] Early data has indicated that cancer patients are at increased risk from COVID-19. Cancer patients, survivors and caregivers are understandably seeking information on how to manage...
COVID-19 and Renal Cancer: A Patient’s Perspective
An excellent and informative podcast on COVID-19 and its impact on kidney cancer patients with Dr. Brian Rini, Vanderbilt-Ingram Cancer Center (US), Dr. Tom Powles, Barts Cancer Centre (UK) and patient advocate Dena Battle, KC Cure (US). [mkd_button size="" type="" text="listen to podcast" custom_class="" icon_pack="font_awesome" fa_icon=""...
COVID-19 and cancer patients
People with compromised immune systems or pre-existing medical conditions, including cancer, may be at increased risk of contracting coronavirus (COVID-19) and increased risk of more severe infection. [mkd_icon icon_pack="font_awesome" fa_icon="circle" size="" custom_size="12" type="square" border_radius="" shape_size="" icon_color="#93bd46" border_color="" border_width="" background_color="" hover_icon_color="" hover_border_color="" hover_background_color="" margin="" icon_animation="" icon_animation_delay="" link=""...
Online Coffee-Chat – March 26
In these difficult and uncertain times, we realize even more our need to stay connected and develop close links with one another. Fortunately we have applications such as FaceTime, Messenger and others to help keep us connected with families and friends near and far. We want...
POSTPONED – National Patient & Cargiver Forum in Montreal
Please be advised that after much deliberation and consultation the Board of Directors of Kidney Cancer Canada has determined that in the best interest of all concerned (both safety and well-being), that we must postpone our Annual National Patient and Caregiver Forum - scheduled for...
National Patient & Caregiver Forum – Registration now open
POSTPONED [mkd_button size="" type="" text="See notice here" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://www.kidneycancercanada.ca/news/postponed-national-patient-cargiver-forum-in-montreal/" target="_self" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] We are happy to announce that the next Patient, Caregiver, Family and Survivor Forum takes place in Montreal, Saturday, May 9. Presentations are in French and...
Research results on circulating tumour DNA
Research funded by Kidney Cancer Canada, Canadian Urological Association and Kidney Cancer Research Network of Canada Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma Cells in your body are constantly growing, dividing, and dying. When mature cells die, they release their DNA into...
Summary of Kidney Cancer Take-Home Messages from ASCO GU 2020
Source: International Kidney Cancer Coalition Over 4,000 delegates attended the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco, 13-15 February 2020. The International Kidney Cancer Coalition (IKCC) was present with a booth to raise awareness, and also attended many of the medical and patient advocacy sessions. Please...
Kidney cancer treatment guidelines update
The Kidney Cancer Research Network of Canada updated the kidney cancer treatment guidelines: 2019 – Kidney Cancer Research Network of Canada consensus statement on the role of renal mass biopsy in the management of kidney cancer 2019 – Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada consensus...
New combination treatment available in Canada
Good news for kidney cancer patients and their families The combination treatment pembrolizumab (Keytruda®) with axitinib in first line treatment for advanced renal cell carcinoma is available in Canada through the manufacturer's patient care program. If your doctor believes that this therapy is suitable for you, they...
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC)
We draw your attention to this media release distributed through Cision. This therapy for treatment of metastatic kidney cancer needs evaluation by the pan-Canadian Oncology drug review process and then, if recommended, requires government and private insurers to enter into price negotiation. Kidney Cancer Canada / Cancer...
Coffee Chats in Montreal and Surrounding areas
MONTREALERS SAVE THE DATES! We hold Coffee Chats from 2 to 4 pm on: January 26 - Laval Presse Café Centropolis 1794 Pierre Péladeau, Laval pressecafe.com February 16, Montreal La Finca café & bureau 1067 de Bleury, Montreal 5-minute walk from Place-d'Armes metro station lafinca.ca March 8, Brossard Le café du Théâtre - Quartier DIX30 6000, de Rome...
Acupuncture introduced as a complementary therapy at the Quebec Cancer Foundation in partnership with the Collège de Rosemont
Source: The Quebec Cancer Care Foundation The Quebec Cancer Foundation innovates once again in providing support for people with cancer and their loved ones by offering free acupuncture sessions at its Montreal Regional Center and Lodge. In addition to the medical procedures used in treating cancer, the healthcare system widely recommends the...
Past meetings and webinars updated
Our 2019 meetings and webinars are now updated. [mkd_button size="" type="" text="WATCH PAST MEETINGS" custom_class="" icon_pack="font_awesome" fa_icon="" link="https://www.kidneycancercanada.ca/news-events/watch-past-meetings/" target="_self" color="" hover_color="" background_color="" hover_background_color="" border_color="" hover_border_color="" font_size="" font_weight="" margin=""] ...
Maritimes patient and caregiver meeting live streamed
Hey, we're trying something new! Join us on Sunday, November 10 as we live stream on Facebook the Maritimes Patient, Caregiver, Family and Survivor Meeting. You can ask questions during the live feed. See you on www.facebook.com/KidneyCancerCanada PST 10 am | MST 11 pm | CST...
Health Canada Approves Ipsen’s CABOMETYX™ (cabozantinib) for the First-Line Treatment of Adults with Advanced Renal Cell Carcinoma
Source: Ipsen Biopharmaceuticals Canada Inc. CABOMETYXTM demonstrated a statistically significant, 52 per cent reduction in the risk of progression or death compared with sunitinibi, giving Canadian patients with intermediate or poor risk a new oral first-line treatment option in their fight against advanced kidney cancer MISSISSAUGA, ON, Oct. 15,...
Kidney cancer patients, caregivers, family and survivors join an informative session in Hamilton, ON
The Urologic Cancer Centre for Research & Innovation and Kidney Cancer Canada – Cancer du rein Canada host a free kidney cancer information session to provide patients, caregivers, family and survivors with the information and tools to help them be an active participant in their...
For female cancer survivors in Toronto and surrounding areas
Come try out different types of exercises at the University of Toronto Researchers from the University of Toronto are performing a study investigating how female cancer survivors feel during and after different types of exercise. If you are a woman diagnosed with cancer and: 18-75 years old ...
Webinar recording – Overview of the new discussion forum
https://vimeo.com/359541339 We are ready to launch the new discussion forum platform “Kidney Cancer Canada – Cancer du rein Canada Private Chat Room”. If you are already a member of the old discussion forum you will receive your new login information later today. If you are not a member...
Launch of the new discussion forum platform
We are ready to launch the new discussion forum platform “Kidney Cancer Canada – Cancer du rein Canada Private Chat Room”. To ease the transition, we will hold a webinar to introduce the new platform on Thursday, September 12, 9 am Eastern. To register please click...
NEWFOUNDLAND MEETING 2019
The Kidney Cancer Canada team hosts a Patient, Caregiver, Family and Survivor Meeting in St. John's, Newfoundland. This interactive forum features the latest information on kidney cancer treatment and what survivors should know about follow-up care. The session also gives patients, caregivers, family members and survivors a...
Thousands of Canadians begin to follow Olympic Gold Medalist in the MOVE to Beat Cancer
[vc_video link="https://www.youtube.com/watch?v=Vkroh1znnK4" align="center"][vc_column_text]Toronto, Ontario, Tuesday August 7, 2019 –Olympic Gold Medalist, Adam Kreek is on the MOVE to Beat Cancer to inspire others to get their MOVE on and support patient programs and research. Canadians can begin today to sign up at movetobeatcancer.org and pledge to join Adam in their self-designed MOVE and...
Kidney Cancer Canada Nursing Excellence Award in honour of Tony Clark
By Nesan Bandali When I was asked to write a few words about my experience as an oncology nurse, it took me a while to go back through my life to pinpoint the time that I decided I wanted to be a nurse. For as long as...
Dr. Daniel Heng receives Meritorious Service Cross from Governor General
Internationally recognized leader in kidney cancer research Dr. Daniel Heng created the world’s largest kidney cancer patient database. Containing data from over 7 000 patients worldwide, this comprehensive analytical tool allows specialists to better diagnose and treat patients with the disease. We wish Dr. Daniel Heng...
GU-ASCO 2019 Highlights
Source: International Kidney Cancer Coalition Note: The following summary was prepared by patient advocates for the benefit of patient organisations who focus on kidney cancer. While this summary has been medically reviewed, the information contained herein is based upon public data shared at this meeting and...
New uploads: Kidney Cancer Video Knowledge Library
New videos uploaded to the Kidney Cancer Video Knowledge Library: Are clinical trials a last resort treatment? Are there any dangers when having a biopsy? Can I trust diagnostic information on the internet? How can I...
The downside of inflammatory news about cancer
Source: First Opinion My inbox exploded this week with messages asking about a widely circulated news story claiming that researchers had found the cure for cancer. My heart sunk. And then I got mad. It began with an article in the Jerusalem Post story...
New kidney cancer drug therapy recommended for use in Canada.
Kidney Cancer Canada – Cancer du rein Canada welcomes the decision of the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) to recommend reimbursement of cabozantinib (Cabometyx) in patients with advanced renal cell carcinoma (RCC) who have received at least one prior vascular...
Cabozantinib Quebec Reimbursement Update
Please note: this statement follows our mandate to provide you information on all access issues. Kidney Cancer Canada – Cancer du rein Canada wishes to inform our community about recent developments in Quebec with regards to cabozantinib, a new treatment for patients with advanced renal...
New uploads: Kidney Cancer Video Knowledge Library
New videos uploaded to the Kidney Cancer Video Knowledge Library: How important is kidney cancer research? Should I expect pain after a nephrectomy? What can I expect when waking up from a nephrectomy? What does VEGF...
New uploads: Kidney Cancer Video Knowledge Library
New videos uploaded to the Kidney Cancer Video Knowledge Library: How dangerous is a radical nephrectomy? How do you choose between a partial or radical nephrectomy? How much time does a partial nephrectomy surgery take? How...
Activating Cancer Communities through an Exercise Strategy for Survivors (ACCESS)
A message from Dr Ricardo Rendon and Dr. Lori Wood Dear Kidney Cancer Canada Nova Scotia Community, We wanted to let you know about a new and exciting opportunity for people who have had or currently have kidney cancer in Halifax and Nova...
THE DOCTOR IS IN 24 HOURS A DAY: A first for Canadian Kidney Cancer Patients
A note from Stephen, our Executive Director Today we are very excited to launch a new and unique resource to help you. The Kidney Cancer Video Knowledge Library is a first for patients and caregivers – a depository of hundreds of questions...
Two kidney cancer research awards for 2019
Kidney Cancer Canada | Cancer du rein Canada in collaboration with the Kidney Cancer Research Network of Canada (KCRNC) and the Canadian Urology Association Scholarship Foundation (CUASF) fund two $50,000 research awards for kidney cancer. These awards are possible thanks to the outstanding support...
Summary of Kidney Cancer Take-Home Messages from ESMO 2018
Source: International Kidney Cancer CanadaNote: The following summary was prepared by patient advocates for the benefit of patient organisations who focus on kidney cancer. While this summary has been medically reviewed, the information contained herein is based upon public data shared at this meeting...
Health Canada Approves cabozantinib Giving Physicians and Patients a Novel Second-Line Option in the Fight Against Advanced Renal Cell Carcinoma
SOURCE : Canadian News Wire Release MISSISSAUGA, ON, Sept. 19, 2018 /CNW/ - Ipsen Biopharmaceuticals Canada Inc. today announced the Health Canada approval of CABOMETYX™ (cabozantinib), a once-daily oral tablet,2 indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) who have...
Kidney Cancer Canada announces The B. Lois Smith Kidney Cancer Research Award
Kidney Cancer Canada and the Kidney Cancer Research Network of Canada are pleased to announce an incredible funding opportunity for kidney cancer researchers. The B. Lois Smith Kidney Cancer Research Award supports peer-reviewed research that promotes excellence in kidney cancer research. As a direct...
Kidney Cancer Canada announces 2019-2021 Operating Grant Competition.
Kidney Cancer Canada, the Kidney Cancer Research Network of Canada & The Cancer Research Society fund a significant 2019-2021 Operating Grant competition. One Canadian kidney cancer researcher will receive $120,000 to improve the lives of patients and caregivers. Thank you to all our donors...
The Move to Beat Cancer project launches Canada-wide
Canadians across the country gear up to Move to Beat Cancer. Move to Beat Cancer brings people and their communities together in a dynamic, social and festive way to create awareness about cancer prevention and to raise money for patient programs and research. The...
CANO | ACIO Award of Excellence in Kidney Cancer Nursing
Kidney Cancer Cancer | Cancer du Rein Canada is looking to honour a nurse or group of nurses that has made an exceptional difference to the lives of kidney cancer patients. The Canadian Association of Nurses in Oncology | Association canadienne des infirmières en...
Kidney Canada Canada | Cancer du rein Canada is pleased to welcome Gerry Backs as Director of Development and Donor Relations
Gerry has more than 25 years’ experience providing professional support to local, national and international charities. He built high-performance non-profit teams and managed numerous successful fundraising campaigns all across Canada. Gerry is Certified Fundraising Executive since 1999 and in 2002 he completed a...
Exceptional contributions to cancer research recognized at Canadian Cancer Research Conference
[Canadian Cancer Research Alliance] October 30, 2017 (TORONTO) - The Canadian Cancer Research Alliance (CCRA) announced today the recipients of its biennial awards which recognize significant contributions to cancer research in Canada. “These awards demonstrate CCRA’s continuing recognition of excellence in cancer research,”...
Clinical Trial Opportunity for Newly Diagnosed (Non Metastatic) Kidney Cancer
Guest Blog by Deb Maskens, Kidney Cancer Patient and Patient Advocate As a community of kidney cancer patients, we often hear from patients who are newly diagnosed and looking for treatment options. This summary is written for those patients, and for patient...
Valuable information for Ontario cancer patients – Trillium Drug Program
The Trillium Drug Program (TDP) is intended for Ontario residents who have high prescription drug costs in relation to their net household income. The TDP provides coverage for prescription drug products (in the same manner as the Ontario Drug Benefit program) that are listed on...
Cancer patients celebrate new program for take-home cancer medications in Nova Scotia
-- Province’s investment into the cancer system could eliminate financial hardship for patients -- [CanCertainty] Halifax, Nova Scotia, September 27, 2017 – The CanCertainty Coalition, the united voice of 35 Canadian cancer organizations, applauds the McNeil Government’s decision to address the funding gap for takehome...
Upcoming Patient Education Meetings
LIVE WEBINARUP-TO-THE MINUTE KIDNEY CANCER TREATMENT NEWSSeptember 27, 2017 | 8 pm EDT Dr Christian Kollmannsberger (BC) and Dr Anil Kapoor (ON) bring you the latest treatment information from the European Society Medical Oncology (ESMO) Annual Congress in our National Webinar. Kidney cancer survivor,...
A touching share from the Maritimes
We have come a long way in the treatment of kidney cancer since my husband was diagnosed in 2000. At the time, his prognosis was poor. There was only one treatment available in Canada and the patient response to the drug was very low. David’s...
Cabozantinib pCODR Review – Your Input is needed!
Kidney Cancer Canada is seeking input from kidney cancer patients and their caregivers about their experiences and challenges with kidney cancer and current treatments. The results of this survey will help inform our submission to the pan-Canadian Oncology Drug Review (pCODR) for the drug...
Summary of Kidney Cancer Take-Home Messages from ESMO 2017
Article by the International Kidney Cancer Coalition (IKCC) Note: The following summary was prepared by patient advocates for the benefit of patient organisations who focus on kidney cancer. While this summary has been medically reviewed, the information contained herein is based upon...
Bristol-Myers stop kidney cancer drug tests after early success
(Reuters) - Bristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end the trial well ahead of schedule, despite earlier reporting mixed results on other main goals. The company said a...
Expand your care options: Dr. Daniel Heng on clinical trials
One of the topics on the Kidney Cancer Canada website that gets a lot of attention is the list of clinical trials. We update the list when new trials open and our medical writer speaks regularly with trial researchers. But, what is a clinical...
Are you helping kidney cancer research?
BY DR. NAVEEN BASAPPA and RANJENA MALONI In April 2017, the pan-Canadian Oncology Drug Review (pCODR) called for submissions on whether Axitinib should be used and funded as an equally accessible second-line treatment for metastatic kidney cancer. pCODR asked Kidney Cancer...
Cancer survivor takes helm of Kidney Cancer Canada | Cancer du rein Canada
TORONTO, August 28, 2017: Kidney Cancer Canada | Cancer du rein Canada is pleased to announce the appointment of Stephen Andrew as the Executive Director of the organization. “Stephen has a tremendous passion and dedication to Kidney Cancer Canada | Cancer du rein Canada...
Is Canada a Caring Society? New Report Reveals Progress and Gaps in Supporting Family Carers
SOURCE: Canadian Home Care Association OTTAWA, July 26, 2017 /CNW/ - Over 8 million carers (also referred to as family caregivers) impact the lives of Canadians every day. They provide care and support to loved ones, family members and friends; and contribute over...
Free Ultrasound Screenings for Kidney Cancer mark World Kidney Cancer Day
ADVISORY: TORONTO, ON, June 20, 2017 /CNW/ - Media are invited to attend free kidney cancer ultrasound screenings at the Concourse Level of the OPG building at 700 University Avenue (College and University) on Thursday June 22, 2017. These ultrasound screenings will provide shoppers...
Mayor of Fredericton, N.B. has proclaimed June 22, 2017 World Kidney Cancer Day in his city
Mike O’Brien, Mayor of Fredericton, New Brunswick, has proclaimed June 22nd, 2017 World Kidney Cancer Day in his city. A short presentation to the Mayor and City Council on how far treatments for kidney cancer have come since 2000, where we are now and...
Shocking growth in kidney cancer rates
8 year statistics predict more than 20 percent increase TORONTO, June 20, 2017– More than 6,000 Canadians will be diagnosed with kidney cancer this year. Experts predict from 2012 to 2020, kidney cancer will increase globally by a shocking 22 percent “Populations are...
New Canadian research projects include work to block spread of kidney cancer
BY RANJENA MALONI Kidney Cancer Canada is funding several exciting research projects across the country that are working at ways to stop the spread of kidney cancer and to develop tests so that doctors can determine what drugs will work for individual patients. A partnership...
The CANO | ACIO Award of Excellence in Kidney Cancer Nursing
Kidney Cancer Cancer | Cancer du Rein Canada is looking to honour a nurse or group of nurses that has made an exceptional difference to the lives of kidney cancer patients. The Canadian Association of Nurses in Oncology | Association canadienne des infirmières en oncologie...
Kidney Cancer Canada Ups Benchstrength Adding Accomplished Health Care professionals to Board
MEDIA RELEASE Ottawa, Ontario, April 23, 2017 – Kidney Cancer Canada elected Dr. Anil Kapoor, MD, FRCSC and Dr. Mona Sabharwal, Pharm.D. to its Board of Directors today, bringing significant experience and expertise to the organisation’s leadership. A leading uro-oncologist, Dr. Kapoor is the current...
Founders of Kidney Cancer Canada Receive Meritorious Service Decorations from Governor General
MEDIA RELEASE Two Canadians diagnosed with kidney cancer who filled a gap in the Canadian health care system received Meritorious Service Decorations today from Governor General David Johnston at a ceremony in Ottawa. Deb Maskens and the late Tony Clark, the founders of Kidney Cancer...
Kidney cancer expert shares hopeful new research
Kidney cancer expert shares hopeful new researchby tbnewswatch.com Thunder Bay – Thursday November 19, 2015) – Dr. Anil Kapoor was the keynote speaker at a kidney cancer treatment and emerging therapies public information session on Thursday evening at Thunder Bay Regional Health Sciences Centre...
Kidney cancer expert shares hopeful new research with regional cancer professionals and patients
(Thunder Bay – Thursday November 19, 2015)– Dr. Anil Kapoor, leading researcher and uro-oncologist from St. Joseph’s Healthcare in Hamilton and Chair of the Medical Advisory Board for Kidney Cancer Canada, was the keynote speaker at a kidney cancer treatment and...
There is Hope for Kidney Cancer Patients
There is Hope for Kidney Cancer Patientsby Sarah Chow THUNDER BAY – HEALTH – Kidney cancer is not as common as breast or prostate cancer. We don’t often hear about it in the media, or think about it when we consider our health risks....
Kidney Cancer Patients Turn Experience into Advocacy
Kidney Cancer Patients Turn Experience into AdvocacyBy Sara Chow(published in the Chronicle Journal) For Pat and Lynne Sevean, kidney cancer was not a health concern. That changed when both of them were diagnosed with it in 2014. Neither of them knew much about kidney...
Ontario Uro-Oncologist to lead Canadian group of kidney cancer experts
MEDIA RELEASE Kidney Cancer Canada is pleased to announce leading researcher and Uro-Oncologist, Dr. Anil Kapoor, as the new Chair of its Medical Advisory Board. As the Director of the McMaster Institute of Urology at St. Joseph’s Healthcare Hamilton, Dr. Kapoor knows first-hand the...
Top 10 Research Priorities in Kidney Cancer
What are the top 10 research priorities in kidney cancer Citizen involvement in kidney cancer research prioritization Background Top 10 Research Priorities in Kidney Cancer ...
New Research Chair in Kidney Cancer in Atlantic Canada
Tuesday October 11, 2011 - Moncton, New Brunswick. Dr. Sandra Turcotte has been announced as the new Canadian Cancer Society Research Chair at the Université de Moncton. Born and raised in Chicoutimi, Quebec, Dr. Turcotte earned a Bachelor of Science in Biochemistry as well as...
Sunitinib rechallenge benefited select metastatic renal cell carcinomas
– by Jason Harris - HemOnc Today: Clinical News in Oncology and Hematology Sunitinib rechallenge has potential as a treatment option in select patients with favorable- or intermediate-risk metastatic renal cell carcinoma, according to the results of a trial presented at the 2010 Genitourinary Cancers...
U.S. FDA approves GSK’s Votrient (pazopanib) for mrcc
Votrient, a once-daily, oral medication, is an angiogenesis inhibitor which may help prevent the growth of new blood vessels, thereby blocking the growthof kidney cancer tumors that need blood vessels to survive. The new drug submission (NDS) for Pazopanib is currently under review by Health...
Bayer’s Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
BERLIN, Sept. 22 /PRNewswire/ -- Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with...
Rises in incidence of kidney cancer
Cancer Care Ontario has release a fact sheet detailing the rising incidence of kidney cancer in Ontario and around the world. The attached sheet reports rising incidence rates in women along with contributing factors. Download Information...
Rises in incidence of kidney cancer
Cancer Care Ontario has release a fact sheet detailing the rising incidence of kidney cancer in Ontario and around the world. The attached sheet reports rising incidence rates in women along with contributing factors. Download ...
ABT-869 Trial for Advanced RCC
An Open-Label, Phase 2 Study to Evaluate the Efficacy and Tolerability of ABT-869 in Subjects With Advanced Renal Cell Carcinoma (RCC) Who Have Previously Received Treatment With Sunitinib. This trial is an Open-Label, Phase 2 Study to Evaluate the Efficacy and Tolerability of ABT-869 in...
Avastin approved in EU for rcc
Avastin (bevacizumab) has been approved in Europe for first-line treatment of renal cell carcinoma.As of November 2007, Avastin has not been approved for rcc in either the U.S. or Canada. Avastin is approved in Canada for colorectal cancer, but is not funded in every province....
Pazopanib shows positive results in phase II trials
Pazopanib, another anti-angiogenesis drug, has shown positive results in Phase II trials for advanced kidney cancer. For more information about pazopanib, see: http://www.medicalnewstoday.com/articles/73025.php ...
Axitinib showing promise for rcc
A new drug from Pfizer has demonstrated positive results in Phase II trials in the U.S.Phase III trials are open in the U.S. and some sites in Canada. Axinitib is being studied as a 2nd line treatment for mrcc (clear cell) versus sorafenib (Nexavar) For...